Vascular Endothelial Growth Factor (VEGF) as a Biomarker for Cancer-Associated Venous Thrombosis: A Meta-analysis.

TH Open · 2025 · PMC12020352 · PMID 40276364

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although all three studies showed a trend towards higher levels of VEGF in those patients who subsequently developed a thrombosis versus those who did not, this difference was not statistically significant ( P -value of 0.10).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.